Project title: InveNNta
The InveNNta project runs until the end of October 2015 and its aim is to develop new biosensors and nanomarkers applied to medicine. The new nanodevices and nanostructures will be mainly applied in the diagnosis and therapy of cancer and neurological diseases, as well as in the area of imaging through the development of markers with improved contrast functionalities.
The initiative aims to directly address unsolved needs in health, promoting within the Euro-region Galicia-Northern Portugal, the application of the INL devices developed based on nanotechnology, which support the monitoring and follow-up of patients with complex diseases, with a high economic and social impact, under the new health care models.
INL provides the necessary state of the art scientific equipment to meet these challenges. The development of biosensors for the detection of circulating tumour cells, and the development of nanoparticles for applications in imaging are two relevant research lines of several research groups at INL.
The project also aims to train researchers and technicians in the fields of nanomedicine and technology transfer, converting IDIS and INL in relevant centres in nanotechnology applied to medicine, diagnosis and therapy. The initiative resulted from the effort and the joint commitment of the INL and the Institute of Health Research Santiago (IDIS), through the Foundation Ramón Dominguez.
The project will contribute to build a network of excellence in nanomedicine, in the Euroregion Galicia - North of Portugal, which will work as a platform for further participation in European projects.
InveNNta has a budget of 2.8 million euros and is co-funded within the POCTEP (Operational Programme for Cross-border Cooperation Spain-Portugal), co-financed by the ERDF (European Regional Development Fund).
To see the vídeo about the project, click here and view the english version